Phase 4
N=2,404
Pharmacists as Immunizers to Improve Coverage and Provider/Recipient Satisfaction
Healthy
Bottom Line
View on ClinicalTrials.gov: NCT02868970 ↗Enrolled (actual)
2,404
Serious AEs
—
Results posted
Dec 2024
Primary outcome: Primary: Number of Vaccines Administered by Participating Pharmacies in the Intervention and Non-intervention Communities Before and During the Intervention. — 3,093; 5,011; 6,149; 5,922 Number of vaccines administered
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Meningococcal B (Biological); High-Dose TIV (Biological); Tdap (tetanus-diphtheria-acellular pertussis) (Biological); Meningococcal ACWY (Biological); Herpes Zoster (Biological); Travel Health (Hepatitis A, Hepatitis B, Typhoid Fever) (Biological)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Canadian Immunization Research Network
- Primary completion
- Jul 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Vaccines Administered by Participating Pharmacies in the Intervention and Non-intervention Communities Before and During the Intervention. |
3,093; 5,011; 6,149; 5,922 | — |
| SECONDARY Compare the Number of Flu Vaccine Recipients Who Were Recruited and Completed the Online AEFI Survey Among Intervention Pharmacies Using Active Recruitment Strategies and the Non-intervention Pharmacies Using Passive Recruitment Strategies. |
221; 8 | — |
| SECONDARY Determining the Awareness About Pharmacists as Immunizers and Vaccination Behaviours of the Targeted Public Using Pre-intervention and Post-intervention Knowledge, Attitudes, Beliefs and Behaviours (KABB) Surveys |
850; 852; 724; 680; 166; 122 | — |
| SECONDARY Determining the Attitudes and Beliefs of the Targeted Public About Pharmacists as Immunizers Using Pre-intervention and Post-intervention Knowledge, Attitudes, Beliefs, and Behaviours (KABB) Surveys |
739; 772; 696; 717; 756; 780 | — |
| SECONDARY Determining the Awareness of the National Advisory Committee on Immunization (NACI) Guidelines and the Vaccinating Behaviors of Healthcare Providers Through Pre-intervention and Post-intervention Knowledge, Attitudes, Beliefs and Behaviors (KABB) Surveys |
201; 163; 149; 140; 152; 133 | — |
| SECONDARY Determining the Attitudes and Beliefs of Healthcare Providers Regarding Pharmacists as Immunizers Using Pre-intervention and Post-intervention Knowledge, Attitudes, Beliefs, and Behaviours (KABB) Surveys |
188; 155; 197; 179; 170; 136 | — |
Summary
This project proposes to implement and compare new community pharmacy-based strategies for improving vaccine coverage.
Eligibility Criteria
Inclusion criteria
- For the selection of the four communities include population size (approximately 30,000 adults >18 years of age), stable population, service by a centralized regional hospital and local community hospitals, availability of community pharmacies, interest of community pharmacists (sufficient numbers of pharmacists qualified to provide vaccinations), and lack of substantial health care spill over to adjacent communities.
- Spill over is defined as a pattern of health-care utilization where patients regularly receive care at different regional health centers.
- Intervention communities include Saint John, New Brunswick and New Glasgow/Pictou/Antigonish, Nova Scotia area, which include the smaller towns of Stellarton and Westville, Nova Scotia.
- Control communities include Moncton, New Brunswick and Kentville/New Minas/Wolfville, Nova Scotia, which include the smaller towns of Canning and Coldbrook, Nova Scotia.
Exclusion criteria: Not meeting inclusion criteria
Data sourced from ClinicalTrials.gov (NCT02868970). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.